{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,7,24]],"date-time":"2024-07-24T15:19:32Z","timestamp":1721834372345},"reference-count":10,"publisher":"Oxford University Press (OUP)","issue":"23","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2015,12,1]]},"DOI":"10.2146\/ajhp150171","type":"journal-article","created":{"date-parts":[[2015,11,18]],"date-time":"2015-11-18T16:28:14Z","timestamp":1447864094000},"page":"2061-2063","source":"Crossref","is-referenced-by-count":6,"title":["Probable fenofibrate-induced acute generalized exanthematous pustulosis"],"prefix":"10.1093","volume":"72","author":[{"given":"Anna E.","family":"Power","sequence":"first","affiliation":[{"name":"Monash University, Melbourne, Australia, and Summer Vacation Scholar, Centre of Cardiovascular Research $ Education (CCRE) in Therapeutics, School of Public Health and Preventive Medicine, Alfred Centre, Melbourne"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Linda V.","family":"Graudins","sequence":"additional","affiliation":[{"name":"Pharmacy Department, Alfred Health, Melbourne"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Catriona A.","family":"McLean","sequence":"additional","affiliation":[{"name":"Department of Anatomical Pathology, Alfred Hospital, Melbourne"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ingrid","family":"Hopper","sequence":"additional","affiliation":[{"name":"Alfred Health, and National Health and Medical Research Council Postgraduate Scholar, CCRE"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"286","reference":[{"key":"key\n\t\t\t\t2019041008415280000_b1-0722061","unstructured":"Lipidil (fenofibrate) product information. www.mimsonline.com.au\/Search\/Search.aspx (accessed 2015 Jun 9)."},{"key":"key\n\t\t\t\t2019041008415280000_b2-0722061","doi-asserted-by":"crossref","first-page":"989","DOI":"10.1111\/j.1365-2133.2007.08156.x","article-title":"Risk factors for acute generalized exanthematous pustulosis (AGEP)\u2014results of a multinational case-control study (EuroSCAR)","volume":"157","author":"Sidoroff","year":"2007","journal-title":"Br J Dermatol"},{"key":"key\n\t\t\t\t2019041008415280000_b3-0722061","first-page":"37","article-title":"Pustuloses exanth\u00e9matiques aigu\u00ebs g\u00e9n\u00e9ralis\u00e9es, \u00e1 propos de 4 cas","volume":"107","author":"Beylot","year":"1980","journal-title":"Ann Dermatol Venereol"},{"key":"key\n\t\t\t\t2019041008415280000_b4-0722061","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1034\/j.1600-0560.2001.028003113.x","article-title":"Acute generalized exanthematous pustulosis (AGEP)\u2014a clinical reaction pattern","volume":"28","author":"Sidoroff","year":"2001","journal-title":"J Cutan Pathol"},{"key":"key\n\t\t\t\t2019041008415280000_b5-0722061","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1111\/j.1440-0960.2011.00845.x","article-title":"Acute generalized exanthematous pustulosis","volume":"53","author":"Fernando","year":"2012","journal-title":"Australas J Dermatol"},{"key":"key\n\t\t\t\t2019041008415280000_b6-0722061","doi-asserted-by":"crossref","first-page":"1333","DOI":"10.1001\/archderm.1991.01680080069004","article-title":"Acute exanthematous pustulosis. Analysis of 63 cases","volume":"127","author":"Roujeau","year":"1991","journal-title":"Arch Dermatol"},{"issue":"2","key":"key\n\t\t\t\t2019041008415280000_b7-0722061","first-page":"1","article-title":"Fenofibrate-induced acute generalized exanthematous pustulosis","volume":"4","author":"Morais","year":"2008","journal-title":"Dermatol Online J"},{"key":"key\n\t\t\t\t2019041008415280000_b8-0722061","first-page":"683","article-title":"Acute generalized exanthematous pustulosis\u2014three cases","volume":"85","author":"Martin","year":"1994","journal-title":"Actas Dermosifiliogr"},{"key":"key\n\t\t\t\t2019041008415280000_b9-0722061","unstructured":"Therapeutic Goods Administration, Department of Health, Australian Government. Database of Adverse Event Notifications (DAEN). www.tga.gov.au\/database-adverse-event-notifications-daen (accessed 2014 Dec)."},{"key":"key\n\t\t\t\t2019041008415280000_b10-0722061","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1038\/clpt.1981.154","article-title":"A method for estimating the probability of adverse drug reactions","volume":"30","author":"Naranjo","year":"1981","journal-title":"Clin Pharmacol Ther"}],"container-title":["American Journal of Health-System Pharmacy"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/ajhp\/article-pdf\/72\/23\/2061\/28318916\/ajhp2061.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,9,1]],"date-time":"2019-09-01T17:28:41Z","timestamp":1567358921000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/ajhp\/article\/72\/23\/2061\/5111555"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,12,1]]},"references-count":10,"journal-issue":{"issue":"23","published-print":{"date-parts":[[2015,12,1]]}},"URL":"https:\/\/doi.org\/10.2146\/ajhp150171","relation":{},"ISSN":["1079-2082","1535-2900"],"issn-type":[{"value":"1079-2082","type":"print"},{"value":"1535-2900","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2015,12,1]]},"published":{"date-parts":[[2015,12,1]]}}}